Document is current
Any future updates will be listed below
-
Authors
Patterson, Claire M.
Balachander, Srividya B.
Grant, Iain
Pop-Damkov, Petar
Kelly, Brian https://orcid.org/0000-0002-2222-2822
McCoull, William https://orcid.org/0000-0002-2977-1744
Parker, Jeremy https://orcid.org/0000-0002-4758-3181
Giannis, Michael https://orcid.org/0000-0002-8154-3546
Hill, Kathryn J. https://orcid.org/0000-0002-6061-6208
Gibbons, Francis D. https://orcid.org/0000-0003-1606-1740
Hennessy, Edward J. https://orcid.org/0000-0002-3431-4396
Kemmitt, Paul https://orcid.org/0000-0002-5374-6557
Harmer, Alexander R. https://orcid.org/0000-0002-2254-0345
Gales, Sonya https://orcid.org/0000-0002-9736-4075
Purbrick, Stuart https://orcid.org/0000-0001-7176-8701
Redmond, Sean https://orcid.org/0000-0002-1972-2551
Skinner, Matthew https://orcid.org/0000-0002-9677-3352
Graham, Lorraine https://orcid.org/0000-0002-3406-3080
Secrist, J. Paul https://orcid.org/0000-0003-0447-6295
Schuller, Alwin G. https://orcid.org/0000-0001-9163-5885
Wen, Shenghua
Adam, Ammar
Reimer, Corinne
Cidado, Justin https://orcid.org/0000-0003-1748-4438
Wild, Martin https://orcid.org/0000-0002-6424-1909
Gangl, Eric
Fawell, Stephen E.
Saeh, Jamal
Davies, Barry R. https://orcid.org/0000-0002-5414-9113
Owen, David J. https://orcid.org/0000-0002-9165-1540
Ashford, Marianne B. https://orcid.org/0000-0002-8390-4800
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 19 May 2020
Accepted: 21 December 2020
First Online: 25 January 2021
Competing interests
: The authors declare the following competing interests: C.M.P., S.B.B., I.G., P.P-D., W.M., J.P., K.J.H., F.D.G., E.J.H., P.K., A.R.H., S.G., S.P., S.R., M.S., L.G., J.P.S., A.G.S., S.W. A.A., C.R., J.C., M.W., E.G., S.E.F., J.S., B.R.D., M.B.A are current or former AstraZeneca employees and shareholders. D.J.O., M.G., and B.K. are current or former Starpharma employees and shareholders. M.B.A, I.G, E.J.H, W.M, M. G., B.K, D.J.O., J.P.S are inventors of a patent filed related to the therapeutic dendrimers.
